Fri, Jan 30, 2015, 5:00 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Amarin Corporation plc Message Board

golongin2008 236 posts  |  Last Activity: Jan 29, 2015 11:17 AM Member since: Nov 25, 2008
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Shorts...RIP

    by kiddo1428 Jan 29, 2015 11:05 AM
    golongin2008 golongin2008 Jan 29, 2015 11:17 AM Flag

    Have you ever considered we might get rid of both in on antibiotic....Shorts WITH gonorrhea, which is probably most of them..

  • golongin2008 by golongin2008 Jan 29, 2015 10:49 AM Flag

    Only saying cause everytime I post that it makes a new high a few days later!!!!!

    Go C E M P !!!!

  • golongin2008 by golongin2008 Jan 29, 2015 9:48 AM Flag

    Obviously the company feels that recent studies will indicate the need to go into full blown trials and on an expedited basis, and that requires cash, and lots of it. Better safe than sorry, but let's hope this is the end to the give away secondaries until the price is at least over $5.

  • golongin2008 golongin2008 Jan 28, 2015 3:18 PM Flag

    The company already said that the recovery exhibited by Jordan after the scaffold was implanted is seen in about 2% of those who had his type of spinal cord injury....By simple logic....and I mean simple...there was approximately then a 98% chance that the positive results obtained to date were likely either because of the scaffold, or devine intervention....Take your pick.

  • golongin2008 golongin2008 Jan 28, 2015 1:31 PM Flag

    Why anyone in their right mind would go short on one of the hottest stocks in one of the hottest sectors
    with one of the most positive charts out there, is beyond me. I guess the operative word is "in their right mind".

  • golongin2008 by golongin2008 Jan 28, 2015 9:35 AM Flag

    $38.36... Congrats longs...Just the start...

  • Reply to

    See you at $10.00

    by jwo1960 Jan 27, 2015 11:31 AM
    golongin2008 golongin2008 Jan 27, 2015 10:14 PM Flag

    Play... I see you and I are in another one together...Best of luck to you!

  • Reply to

    See you at $10.00

    by jwo1960 Jan 27, 2015 11:31 AM
    golongin2008 golongin2008 Jan 27, 2015 10:13 PM Flag

    How about a takeover at $16? Definitely doable.

  • golongin2008 golongin2008 Jan 27, 2015 12:01 PM Flag

    2x's gross sales for a medical device company is a very conservative figure, but le't go with that for now.
    My target is much the same frankly, as I posted here yesterday. A 1 billion dollar company. Agree
    basically with your analysis... Good job.
    GLTAL's...

  • golongin2008 golongin2008 Jan 27, 2015 11:38 AM Flag

    Mike....You're talking out of both sides of your mouth. You can't post that the projected market size of ("4,000" spinal cord patients....wrong by the way), won't support a much higher market cap, then say at the same time you're looking for 700% return on your investment, or a market cap for the company well over a billion dollars?? When I mentioned I could easily see a market cap for this company of over a billion if the device is proven out , you dismissed that notion off hand...

    So tell us "Mike"... What do YOU feel the market cap could be if the device obtains FDA approval.
    Stick that lil neck out a bit...We're all waiting...

  • golongin2008 golongin2008 Jan 27, 2015 10:42 AM Flag

    Mike...Have you not considered you can do both....make money AND help your fellow man at the same time?
    First you spout off how bad of an investment longer term NVIV is because the potential target treatment group is too small to justify a large price tag for the company, and now you're into "making money" with this company? As my daddy used to tell me..."Son...sh_t or get off the pot"... Make up you mind man.

  • Reply to

    By all means, don't listen to mikerconfer

    by mikerconfer Jan 26, 2015 8:48 PM
    golongin2008 golongin2008 Jan 26, 2015 10:36 PM Flag

    Mike...Today this is a 150 million dollar company. Chump change in this day and age if you have anything going for you. There is not a medical device company out there that would not pay over a billion dollars for a company with the state of the art device to treat spinal cord injuries. SRPT is a 500 million dollar biotech with a yet to be approved drug to treat about 150 children worldwide each year for an incurable disease. When it comes to conditions and diseases that are the face of a loved one there is not enough money in the world
    to not justify the treatment.

  • Reply to

    By all means, don't listen to mikerconfer

    by mikerconfer Jan 26, 2015 8:48 PM
    golongin2008 golongin2008 Jan 26, 2015 10:13 PM Flag

    Agree....but the great thing about stocks is they don't go from $1.50 to $50 in a straight upward move one day when FDA approval comes in the mail. If things work out,and no safety issues, (and I agree that is a big "if"),
    this stock should gradually move up heading into 2017 (which is only 2 years away). I mean if the stock is $4 by 2017 you've had a return of 50% per annum. Not too shabby if you think about it.

  • Reply to

    By all means, don't listen to mikerconfer

    by mikerconfer Jan 26, 2015 8:48 PM
    golongin2008 golongin2008 Jan 26, 2015 10:08 PM Flag

    Look...It one is truly interested in getting into the detailed specifics of this company I would suggest you read
    Jason Napodano's article of last week on his BioNap site (Twitter) that discusses NVIV. Jason is a CFA and biotech analyst with Zack's. Well worth the read IMHO.

  • golongin2008 golongin2008 Jan 26, 2015 9:56 PM Flag

    An HDE is obviously just the first step in the process of obtaining final FDA approval. The more times they use the device successfully the shorter the time to final FDA approval will come. I've been involved in a company with a spinal device for scoliosis that got approval after18 successful implants with no safety
    issues. The procedures were done under an HDE for children under the ages of 13.

  • Reply to

    By all means, don't listen to mikerconfer

    by mikerconfer Jan 26, 2015 8:48 PM
    golongin2008 golongin2008 Jan 26, 2015 9:49 PM Flag

    Not sure where you're getting your figures "mike" but go to the World Health Organization website under spinal cord injuries and read the first sentence where it states there are between 250,000 to 500,000 spinal cord injuries per year worldwide. Not obviously all result in either full or partial permanent paralysis. However,a simple device like NVIV has invented could be used extensively in almost all cases if just to lesson compression on the spine and effected vertabraes, and increase blood flow to the injured areas, thus resulting in a speedier recovery in general.

    And if the device works in the spine, a like device could probably be effective in other areas of the human skeleton and have further applications. This is not a one trick pony.

  • Reply to

    By all means, don't listen to mikerconfer

    by mikerconfer Jan 26, 2015 8:48 PM
    golongin2008 golongin2008 Jan 26, 2015 9:34 PM Flag

    We all need to understand that the current "study" is being brought under an IDE (Investigational Device Exemption) and if it proves out to be both effective, and safe, the company then intends to proceed with a pivotal trial under a HDE (Humanitarian Device Exemption), the successful completion of which should garner full FDA approval for use.

  • Reply to

    By all means, don't listen to mikerconfer

    by mikerconfer Jan 26, 2015 8:48 PM
    golongin2008 golongin2008 Jan 26, 2015 9:14 PM Flag

    I respectfully disagree with your conclusions. Caution is of course warranted in all stock investing, especially in a new technology brought forth by what is essentially a penny stock company. However, all successful companies start small, and with unproven technology. This is a medical device company, not a drug company.
    Big difference here. You don't have ten years of trials and three major trials to obtain approval. Much faster process. Been in three that started as private deals, and all had FDA approved devices within three years.

    If this works it will be huge. Not kinda huge. Huge. You aren't seeing the future potential for this product.
    If it works half as well for others as it apparently has for Jordan, it will be the go to implant for all major spinal cord trauma. And that will be worldwide...not just here in the U.S. Add to that the potential to implant stem cells within the device to actually activate and grow cells and tissue to help even repair damage to the spinal cord, and you tell me what a company that could produce this is worth....

    Yes...we're at the very early stages here, but your caution, although duly noted, to me, is simply repeating the obvious.

  • Reply to

    chart

    by dasmith333999 Dec 4, 2014 3:36 PM
    golongin2008 golongin2008 Jan 26, 2015 2:09 PM Flag

    Merrill Lynch doesn't even follow the stock.....

  • Reply to

    baird on CEMP

    by eatonshorts Jan 23, 2015 4:20 PM
    golongin2008 golongin2008 Jan 23, 2015 9:03 PM Flag

    Sorry,,, C E M P !!!

AMRN
1.02-0.01(-0.97%)Jan 30 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.